The Next-generation sequencing market is expected to grow from USD 8.26 billion in 2019 to USD 38.48 billion by 2026 at a CAGR of 22.15% from 2020 to 2026.
Next-generation sequencing is a DNA sequencing technology. The procedure of DNA sequencing, which chooses the exact order of nucleotides inside a DNA molecule, is known as Next-generation sequencing. Next-generation sequencing is high throughput sequencing. Using next-generation sequencer, the process products a million DNA molecules and RNA sequences by allowing rapid nucleotide sequencing. The all-in-one approach presented by next-generation sequencing assays minimizes the time essential to identify the cause of a condition, compared to sequential molecular tests, contributing to the enhanced health outcome. In the present situation, liquid biopsies for early discovery and monitoring of cancer, and diversification of the reproductive health market exhibits a substantial capacity for the technology in the near future. The global Next-generation Sequencing market is segregated on the basis of Application as Drug Discovery, Agriculture & Animal Research, Other Applications, and Diagnostics. Based on End User the global market is segmented in Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic Institutes & Research Centers, and Other End Users. Based on Technology the global market is segmented in Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Sequencing by Synthesis, and Other Sequencing Technologies. Based on Product & Services, the global market is segmented in NGS consumables, Services for NGS Platforms, Bioinformatics, Sequencing Services, Presequencing Products & Services, and NGS Platforms.
The global market report provides geographical analysis covering regions, such as North America, Europe, Asia-Pacific, and the Rest of the World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Next-generation Sequencing market has been segmented as below:
By Application
By End-User
By Technology
By Product & Services
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), and others.
Why Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Drug Discovery
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Agriculture & Animal Research
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other Applications
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Diagnostics
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6.1 Introduction
6.2 Hospitals & Clinics
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Pharmaceutical & Biotechnology Companies
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Academic Institutes & Research Centers
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Other End Users
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7.1 Introduction
7.2 Ion Semiconductor Sequencing
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Single-molecule Real-time Sequencing
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Nanopore Sequencing
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Sequencing by Synthesis
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Other Sequencing Technologies
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8.1 Introduction
8.2 NGS consumables
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Services for NGS Platforms
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Bioinformatics
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Sequencing Services
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Presequencing Products & Services
8.6.1 Market Overview
8.6.2 Market Size and Forecast
8.7 NGS Platforms
8.7.1 Market Overview
8.7.2 Market Size and Forecast
9.1 Introduction
9.2 North America
9.2.1 North America Market, By Application
9.2.2 North America Market, By End User
9.2.3 North America Market, By Technology
9.2.4 North America Market, By Product & Services
9.3 Europe
9.3.1 Europe Market, By Application
9.3.2 Europe Market, By End User
9.3.3 Europe Market, By Technology
9.3.4 Europe Market, By Product & Services
9.4 Asia-Pacific
9.4.1 Asia-Pacific Market, By Application
9.4.2 Asia-Pacific Market, By End User
9.4.3 Asia-Pacific Market, By Technology
9.4.4 Asia-Pacific Market, By Product & Services
9.5 Rest of the World
9.5.1 Rest of the World Market, By Application
9.5.2 Rest of the World Market, By End User
9.5.3 Rest of the World Market, By Technology
9.5.4 Rest of the World Market, By Product & Services
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11.1 Illumina, Inc. (US)
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Thermo Fisher Scientific, Inc. (US)
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 BGI Group (China)
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 PerkinElmer Inc. (US)
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Macrogen (South Korea)
11.5.1 Company Overview
11.5.2 Product/Service Landscape
&am